Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Datong Weimin Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturer based in Datong, Shanxi Province, China. As a key subsidiary of the state-owned China Meheco Group, the company specializes in the production of chemical generic drugs and traditional Chinese medicines. Its extensive product portfolio includes various dosage forms such as tablets, capsules, and granules, targeting therapeutic areas like anti-infectives, respiratory health, and cardiovascular diseases. The company operates modern, GMP-certified facilities and is recognized as a high-tech enterprise within its region. Datong Weimin plays a vital role in the industrial supply chain of its parent company, contributing to both domestic drug availability and healthcare infrastructure in North China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Datong Weimin Pharmaceutical.